228 related articles for article (PubMed ID: 7679955)
1. Mice lacking the MHC class II-associated invariant chain.
Viville S; Neefjes J; Lotteau V; Dierich A; Lemeur M; Ploegh H; Benoist C; Mathis D
Cell; 1993 Feb; 72(4):635-48. PubMed ID: 7679955
[TBL] [Abstract][Full Text] [Related]
2. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
3. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
4. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
[TBL] [Abstract][Full Text] [Related]
5. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.
Bikoff EK; Huang LY; Episkopou V; van Meerwijk J; Germain RN; Robertson EJ
J Exp Med; 1993 Jun; 177(6):1699-712. PubMed ID: 8098731
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms.
Shachar I; Elliott EA; Chasnoff B; Grewal IS; Flavell RA
Immunity; 1995 Sep; 3(3):373-83. PubMed ID: 7553001
[TBL] [Abstract][Full Text] [Related]
7. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.
Martin WD; Hicks GG; Mendiratta SK; Leva HI; Ruley HE; Van Kaer L
Cell; 1996 Feb; 84(4):543-50. PubMed ID: 8598041
[TBL] [Abstract][Full Text] [Related]
8. T and B cell receptors discriminate major histocompatibility complex class II conformations influenced by the invariant chain.
Rath S; Lin RH; Rudensky A; Janeway CA
Eur J Immunol; 1992 Aug; 22(8):2121-7. PubMed ID: 1379187
[TBL] [Abstract][Full Text] [Related]
9. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility class II peptide occupancy, antigen presentation, and CD4+ T cell function in mice lacking the p41 isoform of invariant chain.
Takaesu NT; Lower JA; Robertson EJ; Bikoff EK
Immunity; 1995 Sep; 3(3):385-96. PubMed ID: 7553002
[TBL] [Abstract][Full Text] [Related]
12. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
[TBL] [Abstract][Full Text] [Related]
13. The role of the invariant chain in mucosal immunity.
Barrera CA; Almanza RJ; Ogra PL; Reyes VE
Int Arch Allergy Immunol; 1998 Oct; 117(2):85-93. PubMed ID: 9784651
[TBL] [Abstract][Full Text] [Related]
14. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
15. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain.
Bodmer H; Viville S; Benoist C; Mathis D
Science; 1994 Mar; 263(5151):1284-6. PubMed ID: 7510069
[TBL] [Abstract][Full Text] [Related]
16. Truncated MHC class II cytoplasmic and transmembrane domains: effect on plasma membrane expression.
Wade WF; Khrebtukova I; Schreiber KL; McKean DJ; Wade TK
Mol Immunol; 1995 Apr; 32(6):433-46. PubMed ID: 7753052
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody detection of a major self peptide. MHC class II complex.
Murphy DB; Rath S; Pizzo E; Rudensky AY; George A; Larson JK; Janeway CA
J Immunol; 1992 Jun; 148(11):3483-91. PubMed ID: 1375245
[TBL] [Abstract][Full Text] [Related]
18. Invariant chain influences the immunological recognition of MHC class II molecules.
Peterson M; Miller J
Nature; 1990 May; 345(6271):172-4. PubMed ID: 1692393
[TBL] [Abstract][Full Text] [Related]
19. Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules.
Gautam AM; Pearson C; Quinn V; McDevitt HO; Milburn PJ
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):335-9. PubMed ID: 7816844
[TBL] [Abstract][Full Text] [Related]
20. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
